Inventor · disambiguated record
Claude Nicolau
Also filed as: NICOLAU CLAUDE · NICOLAU CLAUDE Y
9 granted patents·22 pending applications·70 citations·filing 1985–2022
85Inventor score
Top patents by PatentIndex Score
31 records- 0196US7772375B2Monoclonal antibodies that recognize epitopes of amyloid-betaAC IMMUNE SA·Filed 2006·Granted Aug 10, 2010·51 cites·15 claims
- 0285US7807175B2Therapeutic vaccineAC IMMUNE SA·Filed 2006·Granted Oct 5, 2010·8 cites·45 claims
- 0379US8603487B2Palmitoylated AB 1-15 in a liposome as a treatment for amyloid associated diseasesPFEIFER ANDREA·Filed 2009·Granted Dec 10, 2013·3 cites·23 claims
- 0471US8409580B2Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancersTOSI PIERRE-FRANCOIS·Filed 2010·Granted Apr 2, 2013·2 cites·19 claims
- 0568US2010297132A1Monoclonal antibodyAC IMMUNE SA·Filed 2009·Application pending·0 cites
- 0667US2016120887A9Tumor eradication by inositol-tripyrophosphateNORMOXYS INC·Filed 2013·Application pending·0 cites
- 0766US7807171B2Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancersAC IMMUNE SA·Filed 2004·Granted Oct 5, 2010·4 cites·21 claims
- 0864US12016886B2Microvascular endothelial cell comprising a nucleic acid encoding an anti-TDP-43 fabALSATECH INC·Filed 2022·Granted Jun 25, 2024·0 cites·10 claims
- 0962US2017027966A1Tumor eradication by inositol-tripyrophosphateNORMOXYS INC·Filed 2016·Application pending·0 cites
- 1061US2012094961A1Tumor eradication by inositol-tripyrophosphateNICOLAU CLAUDE·Filed 2011·Application pending·0 cites
- 1158US2012288896A1Nucleic acid molecules encoding anti-amyloid-beta antibodiesGREFERATH RUTH·Filed 2012·Application pending·0 cites
- 1258US2007135389A1Tumor eradication by inositol-tripyrophosphateNICOLAU CLAUDE·Filed 2006·Application pending·0 cites
- 1358US2012244165A1Methods of treating amyloidosis comprising the use of anti-amyloid beta antibodiesGREFERATH RUTH·Filed 2012·Application pending·0 cites
- 1456US2008312138A1Erythropoietin complementation or replacementNICOLAU CLAUDE·Filed 2008·Application pending·0 cites
- 1554US12016885B2Method of solubilizing TDP-43 protein aggregates in amyotrophic lateral sclerosis using a microvascular endothelial cell expressing an anti-TDP-43 FabALSATECH INC·Filed 2019·Granted Jun 25, 2024·0 cites·9 claims
- 1652US2011070613A1Monoclonal AntibodyAC IMMUNE SA·Filed 2010·Application pending·0 cites
- 1752US2014171394A1Cyclitols and their derivatives and their therapeutic applicationsUNIV STRASBOURG·Filed 2013·Application pending·0 cites
- 1852US2008200437A1Cyclitols and Their Derivatives and Their Therapeutic ApplicationsLEHN JEAN-MARIE·Filed 2007·Application pending·0 cites
- 1950US2021361680A1Inositol-based immunotherapiesNORMOXYS INC·Filed 2019·Application pending·0 cites
- 2050US2006258626A1Use of inositol-tripyrophosphate in treating tumors and diseasesNICOLAU CLAUDE·Filed 2006·Application pending·0 cites
- 2150US2006106000A1Use of inositol-tripyrophosphate in treating tumors and diseasesNICOLAU CLAUDE·Filed 2005·Application pending·0 cites
- 2246US2013190524A1Cyclitols and their derivatives and their therapeutic applicationsLEHN JEAN-MARIE·Filed 2012·Application pending·0 cites
- 2345US2012035137A1Use of inositol-tripyrophosphate in treating tumors and diseasesFYLAKTAKIDOU KONSTANTINA C·Filed 2011·Application pending·0 cites
- 2445US2011294732A1Erythropoletin complementation or replacementNICOLAU CLAUDE·Filed 2011·Application pending·0 cites
- 2544US2012003161A1Use of inositol-tripyrophosphate in treating tumors and diseasesNICOLAU CLAUDE·Filed 2011·Application pending·0 cites
- 2642US2006233758A1Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancersTOSI PIERRE-FRANCOIS·Filed 2005·Application pending·0 cites
- 2742US2006241086A1Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobinNICOLAU CLAUDE·Filed 2006·Application pending·0 cites
- 2841US2005244419A1Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancersTOSI PIERRE-FRANCOIS·Filed 2005·Application pending·0 cites
- 2940US2005255561A1Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancersTOSI PIERRE-FRANCOIS·Filed 2005·Application pending·0 cites
- 3032US12290510B2Polyvalent derivatives of emoxypineRIESNER VERWALTUNGS GMBH·Filed 2020·Granted May 6, 2025·0 cites·10 claims
- 3120US4716114AProcedure for the enhancement of the resistance to arsenite and arsenate of Thiobacillus ferrooxidans and Bacillus subtilisINVERKO IND GMBH & CO KG·Filed 1985·Granted Dec 29, 1987·2 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Claude Nicolau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →